GFM Network News


Zoetis buys livestock data management firm

Performance Beef platform to expand drugmaker's 'precision' production offering

The producer of livestock drugs such as Draxxin, Bovatec and Excede is buying space in the “precision livestock farming” market with a deal for a U.S. livestock data management firm. New Jersey-based Zoetis, which makes drugs and vaccines for the beef and dairy cattle, equine, swine, poultry and sheep sectors as well as cats and […] Read more




Merck to buy Harrisvaccines to boost livestock portfolio

Chicago | Reuters — Merck and Co.’s animal health unit will buy privately-held Harrisvaccines to expand its portfolio of animal vaccines as the U.S. livestock industry seeks new defenses against diseases, the companies said on Thursday. Financial details were not disclosed. The deal, which is expected to close by year-end, follows rival Zoetis’ agreement, announced […] Read more


Widespread antibiotic use reduced disease levels in herds but also sent resistance levels soaring.

Antimicrobial resistance in cattle means big changes coming

Resistance crisis even has drug companies calling for producers to change their ways

Multi-drug resistance to disease-causing bacteria is quickly becoming a complete “game changer” that could cripple the cattle industry’s ability to manage common bovine diseases. “We are really slamming into the end of the antibiotic era,” said Dr. Trisha Dowling, a professor of veterinary pharmacology at the Western College of Veterinary Medicine. “I’ve got 24 different […] Read more



Zoetis says that one of the advantages of ceftiofur is the short withdrawal period

Records show powerful antibiotic for cattle often misused by farmers

Ceftiofur accounted for one-fourth of USDA drug-residue violation reports in 2013

It is one of the most potent antibiotics used by U.S. cattle and dairy farmers. But the strength of the ceftiofur and the frequency with which it’s being misused has created a threat to human health that may overshadow the drug’s effectiveness, a Reuters examination shows. The U.S. Food and Drug Administration cautioned in 2012 […] Read more